Ampicillin
Back to searchMolecule Structure
Scientific Name
Ampicillin
Description of the Drug
Ampicillin is a penicillin derivative used for the treatment of a variety of infections caused by gram-positive and gram-negative bacteria as well as some anaerobes.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00415
http://www.drugbank.ca/drugs/DB00415
Brand Name(s)
Amcill, Amfipen, Ampicillin trihydrate, Ampilar, Britcin, Omnipen, Omnipen (ampicillin), Penbritin, Pfizerpen-a, Polycillin, Principen, Principen ‘125’, Principen ‘250’, Principen ‘500’, Totacillin, Vidopen
Company Owner(s)
Dava Pharmaceuticals Inc, Vitarine Pharmaceuticals Inc, Glaxosmithkline, Hq Specialty Pharma Corp, Watson Laboratories Inc, Mylan Pharmaceuticals Inc, Purepac Pharmaceutical Co, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa, Cosette Pharmaceuticals Inc, Antibiotice Sa
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Bacterial penicillin-binding protein | PROTEIN FAMILY | INHIBITOR | CHEMBL2354204 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL3526 | |||
| PharmGKB | PA448419 | |||
| Human Metabolome Database | HMDB0014559 | |||
| DrugBank | DB00415 | |||
| PubChem: Thomson Pharma | 14827659 | 14802821 | ||
| PubChem | 6249 | 7048611 | ||
| NMRShiftDB | 60058692 | |||
| LINCS | LSM-5761 | |||
| Nikkaji | J4.515B | |||
| PDBe | AIC | |||
| BindingDB | 50350465 | |||
| EPA CompTox Dashboard | DTXSID4022602 | |||
| DrugCentral | 198 | |||
| Brenda | 229160 | 229159 | 191 | 248643 |
| ChemicalBook | CB2247346 | |||
| Guide to Pharmacology | 10896 | |||
| rxnorm | AMPICILLIN | AMPICILLIN TRIHYDRATE | AMPICILLIN (ANHYDROUS) | AMPICILLIN SODIUM |
| KEGG Ligand | C06574 | |||
| ChEBI | 28971 | |||
| ZINC | ZINC000003830218 |
